Saray Rodriguez-Diaz
cima.unav.edu
0000-0001-6799-8002
CIMA
13 papers found
Refreshing results…
Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I
Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome
Lessons from 11C-dihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: is PET imaging of pancreatic beta cell mass feasible?
Cell Reprogramming for Disease Modelling of Primary Hyperoxaluria Type I
CRISPR-Cas9-Mediated In Vivo Susbtrate Reduction Therapy Rescues Phenotype of Primary Hyperoxaluria Type I
CRISPR/Cas mediated disruption of the glycolate oxidase gene is an efficacious treatment for primary hyperoxaluria type I
Pancreatic differentiation of Pdx1-GFP reporter mouse induced pluripotent stem cells
Therapeutic potential of CRISPR/Cas9 mediated in vivo gene editing for primary hyperoxaluria
Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation
Universal in vivo CRISPR/Cas9-mediated knock-in strategy for the treatment of primary hyperoxaluria
Generation and Characterization of Human iPSC line generated from Mesenchymal Stem Cells derived from Adipose Tissue
Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model
Missing publications? Search for publications with a matching author name.